1. Home
  2. BLTE vs HNI Comparison

BLTE vs HNI Comparison

Compare BLTE & HNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • HNI
  • Stock Information
  • Founded
  • BLTE 2018
  • HNI 1944
  • Country
  • BLTE United States
  • HNI United States
  • Employees
  • BLTE N/A
  • HNI N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • HNI Office Equipment/Supplies/Services
  • Sector
  • BLTE Health Care
  • HNI Consumer Discretionary
  • Exchange
  • BLTE Nasdaq
  • HNI Nasdaq
  • Market Cap
  • BLTE 2.1B
  • HNI 2.0B
  • IPO Year
  • BLTE 2022
  • HNI N/A
  • Fundamental
  • Price
  • BLTE $60.48
  • HNI $46.40
  • Analyst Decision
  • BLTE Strong Buy
  • HNI Strong Buy
  • Analyst Count
  • BLTE 4
  • HNI 2
  • Target Price
  • BLTE $96.67
  • HNI $66.50
  • AVG Volume (30 Days)
  • BLTE 32.1K
  • HNI 273.6K
  • Earning Date
  • BLTE 08-08-2025
  • HNI 07-24-2025
  • Dividend Yield
  • BLTE N/A
  • HNI 2.93%
  • EPS Growth
  • BLTE N/A
  • HNI 100.29
  • EPS
  • BLTE N/A
  • HNI 2.80
  • Revenue
  • BLTE N/A
  • HNI $2,538,200,000.00
  • Revenue This Year
  • BLTE N/A
  • HNI $4.50
  • Revenue Next Year
  • BLTE N/A
  • HNI $3.48
  • P/E Ratio
  • BLTE N/A
  • HNI $16.56
  • Revenue Growth
  • BLTE N/A
  • HNI N/A
  • 52 Week Low
  • BLTE $43.70
  • HNI $39.76
  • 52 Week High
  • BLTE $86.53
  • HNI $58.42
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 46.26
  • HNI 48.69
  • Support Level
  • BLTE $58.55
  • HNI $46.26
  • Resistance Level
  • BLTE $62.49
  • HNI $47.58
  • Average True Range (ATR)
  • BLTE 1.81
  • HNI 0.91
  • MACD
  • BLTE -0.40
  • HNI -0.20
  • Stochastic Oscillator
  • BLTE 26.19
  • HNI 22.11

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

Share on Social Networks: